Literature DB >> 8465401

Fifteen years of cutaneous and mucocutaneous leishmaniasis in Bolivia: a retrospective study.

C David1, L Dimier-David, F Vargas, M Torrez, J P Dedet.   

Abstract

This paper present the results of a retrospective study of cases of cutaneous and mucocutaneous leishmaniasis in Bolivia between 1975 and 1991. The total number of cases reported was 4058, 739 of which were mucous. Three different areas of endemic leishmaniasis are defined in Bolivia.

Entities:  

Mesh：

Year:  1993        PMID： 8465401     DOI： 10.1016/0035-9203(93)90398-a

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


  8 in total

1.  Mucocutaneous leishmaniasis: an imported infection among travellers to central and South America.

Authors:  Sukhbir Ahluwalia; Stephen D Lawn; Jeevendra Kanagalingam; Henry Grant; Diana N J Lockwood
Journal:  BMJ       Date:  2004-10-09

2.  Rural campaign to diagnose and treat mucocutaneous leishmaniasis in Bolivia.

Authors:  J P Dedet; R Melogno; F Cardenas; L Valda; C David; V Fernandez; M E Torrez; L Dimier-David; P Lyevre; M E Villareal
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

3.  Evidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recently exposed Bolivian population.

Authors:  A Alcaïs; L Abel; C David; M E Torrez; P Flandre; J P Dedet
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

4.  Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis.

Authors:  Andrea K Boggild; Eric Caumes; Martin P Grobusch; Eli Schwartz; Noreen A Hynes; Michael Libman; Bradley A Connor; Sumontra Chakrabarti; Philippe Parola; Jay S Keystone; Theodore Nash; Adrienne J Showler; Mirjam Schunk; Hilmir Asgeirsson; Davidson H Hamer; Kevin C Kain
Journal:  J Travel Med       Date:  2019-12-23       Impact factor: 8.490

5.  Monitoring toxicity associated with parenteral sodium stibogluconate in the day-case management of returned travellers with New World cutaneous leishmaniasis [corrected].

Authors:  Emily S Wise; Margaret S Armstrong; Julie Watson; Diana N Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2012-06-26

6.  Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel.

Authors:  Michal Solomon; Nadav Sahar; Felix Pavlotzky; Aviv Barzilai; Charles L Jaffe; Abedelmajeed Nasereddin; Eli Schwartz
Journal:  Emerg Infect Dis       Date:  2019-04       Impact factor: 6.883

7.  Transcriptomic and Metabolomic Analysis Revealed Roles of Yck2 in Carbon Metabolism and Morphogenesis of Candida albicans.

Authors:  Karl Liboro; Seong-Ryong Yu; Juhyeon Lim; Yee-Seul So; Yong-Sun Bahn; Hyungjin Eoh; Hyunsook Park
Journal:  Front Cell Infect Microbiol       Date:  2021-03-16       Impact factor: 5.293

8.  Enhancement of a TH1 immune response in amphotericin B-treated mucocutaneous leishmaniasis.

Authors:  Washington R Cuna; Rianed Velasquez; Janeth Riva; Ingrid Guachalla; Celeste Rodríguez
Journal:  J Biomed Biotechnol       Date:  2007
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.